<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T02:51:48Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/3785" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/3785</identifier><datestamp>2025-10-24T10:30:24Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world</dc:title>
   <dc:creator>Sala-Puigdollers, Anna</dc:creator>
   <dc:creator>Velázquez Villoria, Daniel</dc:creator>
   <dc:creator>Figueras-Roca, Marc</dc:creator>
   <dc:creator>Copete, Sergio</dc:creator>
   <dc:creator>Distefano, Laura Natalia</dc:creator>
   <dc:creator>García Arumí, José</dc:creator>
   <dc:creator>Boixadera Espax, Ana</dc:creator>
   <dc:creator>Zarranz-Ventura, Javier</dc:creator>
   <dc:contributor>Institut Català de la Salut</dc:contributor>
   <dc:contributor>[Zarranz-Ventura J, Sala-Puigdollers A, Figueras-Roca M] Institut Clínic d'Oftalmologia, Hospital Clínic, Barcelona, Spain. [Velazquez-Villoria D, Copete S, Distefano L, Boixadera A, García-Arumí J] Servei d'Oftalmologia, Hospital Universitari Vall d’Hebron, Barcelona, Spain.</dc:contributor>
   <dc:contributor/>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Pressió intraocular</dc:subject>
   <dc:subject>Injeccions</dc:subject>
   <dc:subject>Dexametasona</dc:subject>
   <dc:subject>PHENOMENA AND PROCESSES::Ocular Physiological Phenomena::Intraocular Pressure</dc:subject>
   <dc:subject>CHEMICALS AND DRUGS::Polycyclic Compounds::Fused-Ring Compounds::Steroids::Polycyclic Compounds::Fused-Ring Compounds::Steroids::Steroids, Fluorinated::Dexamethasone</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT::Therapeutics::Drug Therapy::Drug Administration Routes::Injections::Injections, Intraocular::Intravitreal Injections</dc:subject>
   <dc:subject>FENÓMENOS Y PROCESOS::fenómenos fisiológicos oculares::presión intraocular</dc:subject>
   <dc:subject>COMPUESTOS QUÍMICOS Y DROGAS::compuestos policíclicos::compuestos con anillos de fusión::esteroides::compuestos policíclicos::compuestos con anillos de fusión::esteroides::esteroides fluorados::dexametasona</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::farmacoterapia::vías de administración de medicamentos::inyecciones::inyecciones intraoculares::inyecciones intravítreas</dc:subject>
   <dc:description>Intraocular pressure; Intravitreal dexamethasone</dc:description>
   <dc:description>Pressió intraocular; Dexametasona intravitrea</dc:description>
   <dc:description>Presión intraocular; Dexametasona intravítrea</dc:description>
   <dc:description>PURPOSE:&#xd;
&#xd;
To evaluate the long-term cumulative probability of intraocular pressure (IOP) elevation with the intravitreal dexamethasone implant (IDI) when used to treat different indications: diabetic macular edema, uveitis, retinal vein occlusion.&#xd;
METHODS:&#xd;
&#xd;
705 IDI injections (429 eyes) were assessed and Kaplan-Meier graphs were generated to assess: the probability of different levels of IOP elevation (IOP≥21, ≥25 or ≥35 mmHg), IOP change ≥10 mmHg, initiation of IOP-lowering treatment, glaucoma surgery, IOP change with repeat injections and IOP elevation in eyes with glaucoma and ocular hypertension (OHT).&#xd;
RESULTS:&#xd;
&#xd;
The cumulative probability of IOP ≥21, ≥25 and ≥35 mmHg was 50%-60%, 25%-30% and 6%-7% at 12-24 months, respectively. The probability of initiating IOP-lowering medication was 31%-54% at 12-24 months. Glaucoma and OHT eyes had a higher probability of mild IOP elevation (≥21 mmHg, 65.1%, 75% and 57.8%, p = 0.01), yet a similar moderate (≥25 mmHg, 22.3%, 28% and 30.2%, p = 0.91) and severe elevation of IOP (≥35 mmHg, 3.7%, 7.1% and 4%, p = 0.71) as normal eyes. Glaucoma surgery was required in only 0.9% cases (4/429). At baseline, 8.8% of the treated eyes had glaucoma, 6.7% OHT and 16.9% were already on IOP-lowering medication.&#xd;
CONCLUSIONS:&#xd;
&#xd;
In the long-term (24 months), IOP elevation is common, generally mild (30% IOP, ≥25 mmHg) and well-tolerated, resolving with topical treatment (54%) and rarely requiring surgery (0.9%).</dc:description>
   <dc:date>2019-02-12T07:04:59Z</dc:date>
   <dc:date>2019-02-12T07:04:59Z</dc:date>
   <dc:date>2019-01-04</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Zarranz-Ventura J, Sala-Puigdollers A, Velazquez-Villoria D, Figueras-Roca M, Copete S, Distefano L, et al. Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world. PLoS One. 2019;14(1):e0209997.</dc:identifier>
   <dc:identifier>1932-6203</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/3785</dc:identifier>
   <dc:identifier>10.1371/journal.pone.0209997</dc:identifier>
   <dc:identifier>30608950</dc:identifier>
   <dc:identifier>WOS:000454952800035</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/3785</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>PLoS One;14(1)</dc:relation>
   <dc:relation>https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0209997</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Public Library of Science</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>